A Win For Tilray, Inc.
Fri, Mar 25, 2022 at 05:30 PM
Tilray, Inc. (TLRY:NASDAQ) shot up at $8.56, representing a gain of 22.8%. On Thu, Mar 24, 2022, TLRY:NASDAQ touched a New 2-Week High of $6.97. The stock got featured on our News Catalysts scanner on Fri, Mar 25, 2022 at 04:53 PM in the 'BIOTECH' category. From Thu, Mar 10, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Mon, Nov 15, 2021 at $13.95 with a volume of 61M+.
About Tilray, Inc. (TLRY:NASDAQ)
Tilray Inc is engaged in sale and development of medical cannabis. Geographically, the company derives majority of its revenue from Canada. The product categories of the company include dried cannabis which include whole flower and ground flower,and cannabis extract which include full spectrum and purified oil drops and capsules.
Top 10 Gainers:
- Clever Leaves Holdings Inc. (CLVR:NASDAQ), 143.04%
- Forge Global Holdings Inc. (FRGE:NYSE), 50.2%
- Fresh Vine Wine Inc. (VINE:NYSEMKT), 33.65%
- NextDecade Corporation (NEXT:NASDAQ), 32.22%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 25.95%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 25.54%
- NexImmune Inc. (NEXI:NASDAQ), 23.12%
- Tilray, Inc. (TLRY:NASDAQ), 22.81%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.63%
- Kidpik Corp. (PIK:NASDAQ), 22.54%